XML 28 R5.htm IDEA: XBRL DOCUMENT v3.24.3Close
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Thousands, $ in Millions
Sep. 28, 2024
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 29,943 $ 29,965
Marketable securities 35,228 31,590
Accounts receivable, net 33,410 29,508
Vendor non-trade receivables 32,833 31,477
Inventories 7,286 6,331
Other current assets 14,287 14,695
Total current assets 152,987 143,566
Non-current assets:    
Marketable securities 91,479 100,544
Property, plant and equipment, net 45,680 43,715
Other non-current assets 74,834 64,758
Total non-current assets 211,993 209,017
Total assets 364,980 352,583 Close
Current liabilities:    
Accounts payable 68,960 62,611
Other current liabilities 78,304 58,829
Deferred revenue 8,249 8,061
Commercial paper 9,967 5,985
Term debt 10,912 9,822
Total current liabilities 176,392 145,308
Non-current liabilities:    
Term debt 85,750 95,281
Other non-current liabilities 45,888 49,848
Total non-current liabilities 131,638 145,129
Total liabilities 308,030 290,437 Close
Commitments and contingencies
Common stock, shares outstanding (in shares) 15,116,786 15,550,061
Common stock, shares issued (in shares) 15,116,786 15,550,061
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,116,786 and 15,550,061 shares issued and outstanding, respectively $ 83,276 $ 73,812
Accumulated deficit (19,154) (214)
Accumulated other comprehensive loss (7,172) (11,452)
Total shareholders’ equity 56,950 62,146 Close
Total liabilities and shareholders’ equity $ 364,980 $ 352,583